Paper16945366
Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1.
Green BD and 5 others. Eur J Pharmacol, 2006. Cited by 98 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1. Papers, record 16945366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16945366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Dipeptidyl-Peptidase IV Inhibitors | Major topic |
| Glucagon-Like Peptide 1 | Major topic |
| Hypoglycemic Agents | Major topic |
| Metformin | Major topic |
| Analysis of Variance | |
| Animals | |
| Blood Glucose | |
| Cell Line | |
| Dipeptidyl Peptidase 4 | |
| Fasting | |
| Glucose | |
| Insulin | |
| Insulin Secretion | |
| Mice | |
| Mice, Obese | |
| Time Factors |
Source PubMed
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41088738 | Gastric Emptying Delay with Pre-Meal Administration of Metformin and Anagliptin in Type 2 Diabetes: Effects on Postprandial Glucose and Triglyceride Levels in a Two-Case Report. | Am J Case Rep | 2025 | https://conductscience.org/library/papers/41088738 | PubMed |
| 38675438 | View on Metformin: Antidiabetic and Pleiotropic Effects, Pharmacokinetics, Side Effects, and Sex-Related Differences. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38675438 | PubMed |
| 38617792 | Understanding the action mechanisms of metformin in the gastrointestinal tract. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38617792 | PubMed |
| 38612893 | Metformin: A Dual-Role Player in Cancer Treatment and Prevention. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38612893 | PubMed |
| 38023603 | Mechanism of Action of Natural Dipeptidyl Peptidase-IV Inhibitors (Berberine and Mangiferin) in Experimentally Induced Diabetes with Metabolic Syndrome. | Int J Appl Basic Med Res | 2023 | https://conductscience.org/library/papers/38023603 | PubMed |
| 37240739 | Prior to versus after Metformin Treatment-Effects on Steroid Enzymatic Activities. | Life (Basel) | 2023 | https://conductscience.org/library/papers/37240739 | PubMed |
| 36692817 | A novel combination of sitagliptin and melatonin ameliorates T2D manifestations: studies on experimental diabetic models. | J Endocrinol Invest | 2023 | https://conductscience.org/library/papers/36692817 | PubMed |
| 35673499 | Assessment of resveratrol on diabetes of zebrafish (Danio rerio). | J Diabetes Metab Disord | 2022 | https://conductscience.org/library/papers/35673499 | PubMed |
| 35059248 | Dipeptidyl peptidase-4 inhibitor improves glycemic variability in multiple daily insulin-treated type 2 diabetes: a prospective randomized-controlled trial. | Diabetol Int | 2022 | https://conductscience.org/library/papers/35059248 | PubMed |
| 34888012 | Effect of glycemic control on markers of subclinical atherosclerosis in patients with type 2 diabetes mellitus: A review. | World J Diabetes | 2021 | https://conductscience.org/library/papers/34888012 | PubMed |
| 33570554 | DPP4 Activity, Hyperinsulinemia, and Atherosclerosis. | J Clin Endocrinol Metab | 2021 | https://conductscience.org/library/papers/33570554 | PubMed |
| 32993632 | Assessment of antidiabetic potential and phytochemical profiling of Rhazya stricta root extracts. | BMC Complement Med Ther | 2020 | https://conductscience.org/library/papers/32993632 | PubMed |
| 32724076 | Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans. | Nat Commun | 2020 | https://conductscience.org/library/papers/32724076 | PubMed |
| 30804991 | Combined Fluoxetine and Metformin Treatment Potentiates Antidepressant Efficacy Increasing IGF2 Expression in the Dorsal Hippocampus. | Neural Plast | 2019 | https://conductscience.org/library/papers/30804991 | PubMed |
| 30688410 | Efficacy of metformin on postprandial plasma triglyceride concentration by administration timing in patients with type 2 diabetes mellitus: A randomized cross-over pilot study. | J Diabetes Investig | 2019 | https://conductscience.org/library/papers/30688410 | PubMed |
| 30584410 | Profiles of Circulating MiRNAs Following Metformin Treatment in Patients with Type 2 Diabetes. | J Med Biochem | 2018 | https://conductscience.org/library/papers/30584410 | PubMed |
| 29188065 | High circulating plasma dipeptidyl peptidase- 4 levels in non-obese Asian Indians with type 2 diabetes correlate with fasting insulin and LDL-C levels, triceps skinfolds, total intra-abdominal adipose tissue volume and presence of diabetes: a case-control study. | BMJ Open Diabetes Res Care | 2017 | https://conductscience.org/library/papers/29188065 | PubMed |
| 28469250 | Development of a Novel Zebrafish Model for Type 2 Diabetes Mellitus. | Sci Rep | 2017 | https://conductscience.org/library/papers/28469250 | PubMed |
| 27862873 | Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes. | Diabetes Obes Metab | 2017 | https://conductscience.org/library/papers/27862873 | PubMed |
| 27351380 | The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial. | PLoS Med | 2016 | https://conductscience.org/library/papers/27351380 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16945366
GET https://conductscience.org/api/papers/v1/16945366/cited_by?page=2